JPMorgan on Novavax (NVAX): 'Share Gain Likely Short-Lived Given Gap 2025 Commercial Year'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 9.20 -0.2 (2.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.40 | 52 Week High | $9.23 | |||
| Open | $9.37 | 52 Week Low | $1.16 | |||
| Day High | $9.39 | P/E | N/A | |||
| Day Low | $8.95 | EPS | $-0.30 | |||
| Volume | 1,486,909 | |||||
